Simon Allen
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Simon Allen
Earlier roles on record: CEO at Anebulo Pharmaceuticals, Inc. (ANEB) until October 6, 2023 and Board Member at Anebulo Pharmaceuticals, Inc. (ANEB) until October 5, 2023. Anebulo Pharmaceuticals, Inc. reported in an 8-K filed October 6, 2023 that Simon Allen resigned as Board of Directors, effective October 5, 2023. Anebulo Pharmaceuticals, Inc. reported in an 8-K filed October 6, 2023 that Simon Allen was terminated as Chief Executive Officer, effective October 6, 2023. The proxy statement of Anebulo Pharmaceuticals, Inc. reports total compensation of $2,120,841 for Simon Allen in fiscal 2022, including a base salary of $187,500.
“In connection with his termination, Mr. Allen resigned from the Company's Board of Directors (the "Board") on October 5, 2023.”
“On October 6, 2023, Anebulo Pharmaceuticals, Inc., a Delaware corporation (the "Company"), terminated without cause the employment of Simon Allen, the Company's Chief Executive Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-10-06
-
Start not stated–2023-10-05
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Anebulo Pharmaceuticals, Inc. (ANEB) | President and Chief Executive Officer | $187,500 | $2,120,841 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.